There is substantial variation between individuals in the immune response to vaccination. In
this review, we provide an overview of the plethora of studies that have investigated factors …

The effectiveness of vaccination against measles, the leading cause of vaccine-preventable
deaths in infants globally, is greatly impacted by the level of maternal antibody to measles …

Background Measles is an important cause of death in children, despite the availability of
safe and cost-saving measles-containing vaccines (MCVs). The first MCV dose (MCV1) is …

Background Vaccinating infants with a first dose of measles-containing vaccine (MCV1)
before 9 months of age in high-risk settings has the potential to reduce measles-related …

Maternal and cord measles and rubella antibodies were compared in 15 populations from
Brazil, Ecuador, Chile, India, Jordan, Nigeria, South Africa, Taiwan, and the United States …

Background The objectives of this review were to evaluate the effect of age at administration
of the first dose of a measles-containing vaccine (MCV1) on protection against measles and …

This module is part of the series The Immunological Basis for Immunization, which was
initially developed in 1993 as a set of eight modules focusing on the vaccines included in …

Summary Objectives Maternal Plasmodium falciparum-specific antibodies may contribute to
protect infants against severe malaria. Our main objective was to evaluate the impact of …

In order to investigate the feasibility of measles vaccination before the age of 9 months the
duration of passive immunity against measles was estimated by conducting a longitudinal …

目的了解四川省人群中麻疹抗体水平, 评价免疫策略的效果, 为针对麻疹的免疫决策提供科学
依据. 方法于2010 年按照麻疹发病率分层随机抽取6 个抽样点(8 个县区), 共调查1 269 人 …